Ontology highlight
ABSTRACT:
SUBMITTER: Adhikari H
PROVIDER: S-EPMC6128905 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
Adhikari Hema H Counter Christopher M CM
Nature communications 20180907 1
In human cancers, oncogenic mutations commonly occur in the RAS genes KRAS, NRAS, or HRAS, but there are no clinical RAS inhibitors. Mutations are more prevalent in KRAS, possibly suggesting a unique oncogenic activity mediated by KRAS-specific interaction partners, which might be targeted. Here, we determine the specific protein interactomes of each RAS isoform by BirA proximity-dependent biotin identification. The combined interactomes are screened by CRISPR-Cas9 loss-of-function assays for pr ...[more]